GOMILIXIMAB
UNII 8Z13S29R5A

Substance Identification & Data

This profile provides standardized clinical and technical data for Gomiliximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8Z13S29R5A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 357613-86-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8Z13S29R5A

CAS Registry Number

357613-86-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GOMILIXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C26448

National Cancer Institute reference terminology for clinical and research data.

INN ID

8443

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OO-24

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gomiliximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GOMILIXIMAB

LUMILIXIMAB

Common Names & Synonyms

GOMILIXIMAB [USAN]

IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER

LUMILIXIMAB [INN]

LUMILIXIMAB [MART.]

LUMILIXIMAB [WHO-DD]

PRIMATIZED ANTI-CD23